Effect of prophylactic use of vitamin D on acquired myopenia in ICU

Effect of prophylactic use of vitamin D in the ICU on patients with ICU acquired diseases

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000033330

Enrollment

Unknown

Registered

2020-05-28

Start date

2020-08-30

Completion date

Unknown

Last updated

2020-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ICU Acquired Myopathies

Interventions

experimental group:Vitamin D2000U injected by muscle

control group:Physiological saline 0.5ml once per muscle injection

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. ICU patients admitted to the seventh Affiliated Hospital of Sun Yat sen University; 2. Patients with a predicted hospital stay >= 3 days; 3. Patients who are willing to sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients younger than 18 or older than 80 years old; 2. Patients with malnutrition or neuromuscular diseases when they stay in ICU; 3. Patients with lower extremity edema.

Design outcomes

Primary

Measure	Time frame
Cross-sectional area of quadriceps femoris;28-day mortality;25-OH-VD;	—

Countries

China

Contacts

Public ContactLiang Luo

The seventh Affiliated Hospital of Sun Yat sen University

luoliang@mail.sysu.edu.cn+86 13725150091

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026